Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
14 studies found for:    renal denervation | Medtronic [Lead]
Show Display Options
Rank Status Study
1 Active, not recruiting Renal Denervation in Patients With Uncontrolled Hypertension - SYMPLICITY HTN-4
Conditions: Hypertension;   Vascular Diseases;   Cardiovascular Diseases
Interventions: Device: Renal Denervation;   Device: Sham Renal Denervation
Phase: Phase 3
Sponsor: Medtronic Vascular
Study Start: October 2013
Primary Completion: July 2014
2 Active, not recruiting Renal Denervation by MDT-2211 System in Patients With Uncontrolled Hypertension
Condition: Uncontrolled Hypertension
Intervention: Device: MDT-2211 Renal Denervation System
Phase: Phase 3
Sponsor: Medtronic Vascular
Study Start: July 2012
Primary Completion: June 2015
3 Active, not recruiting
Has Results
Renal Denervation in Patients With Uncontrolled Hypertension (Symplicity HTN-2)
Condition: Uncontrolled Hypertension
Intervention: Device: Renal Denervation (Symplicity® Renal Denervation System)
Phase:
Sponsor: Medtronic Vascular
Study Start: June 2009
Primary Completion: September 2010
4 Completed Renal Denervation in Patients With Refractory Hypertension
Condition: Hypertension
Intervention: Device: Renal Denervation
Phase:
Sponsor: Medtronic Vascular
Study Start: September 2008
Primary Completion: May 2013
5 Completed Renal Denervation in Patients With Refractory Hypertension
Condition: Hypertension
Intervention: Device: Ardian Symplicity™  Catheter
Phase: Phase 1
Sponsor: Medtronic Vascular
Study Start: June 2007
Primary Completion: May 2013
6 Active, not recruiting Renal Denervation in Patients With Chronic Heart Failure & Renal Impairment Clinical Trial
Condition: Heart Failure
Intervention: Procedure: Renal Denervation
Phase: Phase 4
Sponsor: Medtronic Vascular
Study Start: October 2011
Primary Completion: February 2015
7 Completed Renal Denervation in Patients With Refractory Hypertension
Condition: Hypertension
Intervention: Device: Symplicty(TM) Catheter System
Phase:
Sponsor: Medtronic Vascular
Study Start: April 2008
Primary Completion: May 2013
8 Active, not recruiting Renal Denervation in Patients With Uncontrolled Hypertension (SYMPLICITY HTN-3)
Condition: Uncontrolled Hypertension
Intervention: Device: Renal denervation (Symplicity Catheter System)
Phase: Phase 3
Sponsor: Medtronic Vascular
Study Start: September 2011
Primary Completion: December 2013
9 Active, not recruiting Multi-electrode Radiofrequency Renal Denervation System Feasibility Study
Condition: Uncontrolled Hypertension
Intervention: Device: Medtronic Multi-electrode Radiofrequency (RF) Renal Denervation system
Phase:
Sponsor: Medtronic Vascular
Study Start: September 2012
Primary Completion: March 2014
10 Terminated Single-arm Study of Symplicity™ Renal Denervation System in Patients With Uncontrolled HyperTensioN in India
Condition: Adults With Uncontrolled Hypertension
Intervention: Device: Symplicity renal denervation system
Phase: Phase 3
Sponsor/Collaborators: Medtronic Vascular;   Medtronic
Study Start: October 2013
Primary Completion: November 2014
11 Recruiting Global SYMPLICITY Registry
Conditions: Hypertension;   Diabetes Mellitus;   Heart Failure;   Chronic Kidney Disease;   Sleep Apnea
Intervention: Device: Medtronic Renal Denervation System
Phase: Phase 4
Sponsor: Medtronic Vascular
Study Start: February 2012
Primary Completion: August 2016
12 Completed Renal Denervation in End Stage Renal Disease Patients With Refractory Hypertension
Conditions: Kidney Failure, Chronic;   Renal Dialysis
Intervention: Device: Renal Denervation with a catheter-based procedure
Phase: Phase 1
Sponsor: Medtronic Vascular
Study Start: September 2008
Primary Completion: December 2008
13 Completed Native Kidney Denervation in Patients With End Stage Renal Disease
Condition: End Stage Renal Disease
Intervention: Device: Ardian Catheter
Phase: Phase 1
Sponsor: Medtronic Vascular
Study Start: October 2007
Primary Completion:
14 Not yet recruiting Renal Nerve Denervation in Patients With Hypertension and Paroxysmal Atrial Fibrillation
Conditions: Atrial Fibrillation;   Hypertension
Interventions: Drug: Renal nerve denervation;   Device: Cryoablation
Phase:
Sponsor: Medtronic Atrial Fibrillation Solutions
Study Start: November 2014
Primary Completion: March 2018

Indicates status has not been verified in more than two years